Biostartup Challenges

Chris and Marc discuss the rising costs of FDA approval for biotech startups, leading to challenges in funding and acquisition by big pharma companies. Vijay highlights the unique aspects of digital therapeutics and computational medicine, suggesting a potential shift in economic profiles for these startups.